Immunological Medicines for Poultry
Immunological veterinary medicinal products, including vaccines, are authorised for poultry.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
PRIMUN IB-ND DUO
|
Newcastle-Krankheit, Infektiöse Bronchitis
|
Laboratorios Calier S.A., Spanien
|
PEI.V.11966.01.1 |
28.01.2019 |
Huhn |
PharmNet.Bund
|
PRIMUN BRONCHITIS H120
|
Infektiöse Bronchitis
|
Laboratorios Calier S.A., Spanien
|
PEI.V.11967.01.1 |
15.04.2019 |
Huhn |
PharmNet.Bund
|
Cevac MD Rispens
|
Marek'sche Krankheit
|
Ceva Tiergesundheit GmbH
|
PEI.V.11975.01.1 |
31.07.2020 |
Huhn |
|
Nextmune
|
Infektiöse Bursitis
|
Ceva Tiergesundheit GmbH
|
PEI.V.11992.01.1 |
06.07.2020 |
Huhn |
PharmNet.Bund
|
Avishield IB GI-13
|
Infektiöse Bronchitis
|
GENERA Inc., Kroatien
|
PEI.V.11998.01.1 |
27.03.2020 |
Huhn |
PharmNet.Bund
|
Nobilis Salenvac ETC
|
Salmonellen-Infektion
|
Intervet Deutschland GmbH
|
PEI.V.12006.01.1 |
30.03.2020 |
Huhn |
|
Avishield IBD Plus
|
Infektiöse Bursitis
|
Genera Inc., Kroatien
|
PEI.V.12013.01.1 |
30.06.2020 |
Huhn |
PharmNet.Bund
|
RP Vacc
|
Paramyxovirose der Taube, Rotavirus-Infektion der Taube
|
Pharmagal Bio, spol.s.r.o., Slowakei
|
PEI.V.12101.01.1 |
06.12.2021 |
Taube |
PharmNet.Bund
|
PRIMUN SALMONELLA T
|
Salmonellen-Infektion
|
Laboratorios Calier S.A., Spanien
|
PEI.V.12106.01.1 |
13.07.2022 |
Huhn |
PharmNet.Bund
|
PRIMUN GUMBORO W2512
|
Infektiöse Bursitis
|
Laboratorios Calier S.A., Spanien
|
PEI.V.12107.01.1 |
10.02.2022 |
Huhn |
PharmNet.Bund
|
AviPro IB-ND C131
|
Infektiöse Bronchitis, Newcastle-Krankheit
|
Elanco GmbH
|
PEI.V.12115.01.1 |
19.07.2023 |
Huhn |
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 530 in BAnz AT 16.06.2025 B4.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.